Peptides for cats
Peptides for cats
Last reviewed 2026-08-28 · 6 sources
The direct answer
Why cats are different, and why it matters
Cats are not small dogs. Their liver lacks some of the enzyme machinery that other species use to process and clear drugs, which is the well-known reason a number of medicines and supplements that are fine for dogs are dangerous for cats. That does not mean any specific peptide is toxic to cats - nobody has tested it - but it does mean you cannot assume a dog protocol is safe by shrinking the dose. The usual reasoning behind pet-peptide dosing, scale it to body weight, quietly assumes the animal handles the compound the same way. In cats, that assumption is exactly the one that fails most often.
The evidence gap is a canyon
For dogs there is at least pharmacokinetic data and a rich rodent literature to argue from. For cats there is neither. The studies behind BPC-157 and TB-500 do not include cats; the healing claims are rat data; and the handling data is canine. So a claim like "this dose is safe for a 5 kg cat" is not a cautious reading of thin evidence - it is a number with no feline evidence under it at all.
What owners hope it does
The goals mirror the dog list: wound and soft-tissue healing, gut problems such as IBD, appetite and condition in older cats, and skin or coat issues. Several of those overlap with serious, diagnosable senior- cat diseases - chronic kidney disease, hyperthyroidism, dental pain, cancer - that need a workup rather than a general repair peptide. Reaching for a vial can delay the diagnosis that actually matters.
The cancer caution applies here too
BPC-157 and TB-500 grow new blood vessels, which tumors depend on, so the standard advice to avoid them in an animal with known or suspected cancer holds for cats as much as dogs. Cancer is not rare in older cats. If anything about your cat's health has changed, that is a reason to see a veterinarian, not a reason to start a peptide.
The full safety and legality picture, including how FDA guidance treats compounding for non-food animals, is here: are peptides safe for pets?
Questions people ask
Can you give cats BPC-157 or TB-500?
People do, usually copying dog protocols, but cats are the species where that is least defensible. Cats metabolize many drugs differently from dogs and humans - their livers lack some of the enzymes that clear certain compounds - so dog-derived assumptions do not transfer cleanly. On top of that, there is essentially no cat-specific research on these peptides. It is off-label use of an unapproved compound in the animal we know least about here.
Is there any research on peptides in cats?
Almost none. The rodent studies behind BPC-157 and TB-500 do not include cats, and the small amount of carnivore pharmacokinetic work that exists is in dogs, not cats. Any dose or safety claim for cats is extrapolation, and cats are exactly the species where extrapolation from other animals is riskiest.
What do cat owners use peptides for?
The same broad goals as dogs: soft-tissue and wound healing, gut problems like IBD, kidney and appetite issues in older cats, and coat or skin conditions. But the feline evidence for any of it is weaker than the already-thin dog evidence, so the honest answer is that these are hopes, not established uses.
What is the safest thing to do for an older cat?
Start with your veterinarian, not a vial. Cats hide illness well and several common senior-cat problems - kidney disease, hyperthyroidism, dental pain, cancer - need diagnosis, not a general-purpose repair peptide. A peptide that grows blood vessels is a specific concern if cancer is present, which is not rare in older cats.
Keep reading
Sources
There is no feline-specific research to cite for these peptides; the sources below are the carnivore and mechanistic data people extrapolate from, plus the cancer and regulatory context. That absence is itself the point.
- [1]Pharmacokinetics, distribution, metabolism, and excretion of BPC 157 in rats and dogsstudyBPC-157's absorption and clearance were characterized in dogs among other species - one of the few pieces of canine-specific data that exists for the compound, and pharmacokinetic, not efficacy. Accessed 2026-08-28.
- [2]Multifunctionality and Possible Medical Application of the BPC 157 Peptide - Literature and Patent ReviewreviewReviews the animal-model evidence that BPC-157 accelerates healing of tendon, ligament, muscle and gut tissue, and that it promotes new blood vessel growth (angiogenesis) - the same mechanism behind the caution in animals with cancer. Almost all of this work is in rodents. Accessed 2026-08-28.
- [3]Thymosin beta4: actin-sequestering protein moonlights to repair injured tissuesstudyThymosin beta-4, the parent molecule of TB-500, promotes cell migration, new blood vessel growth and tissue repair - the mechanism cited for its use on soft-tissue and tendon injuries. Accessed 2026-08-28.
- [4]Cancer in pets (American Veterinary Medical Association)referenceThe AVMA states roughly 1 in 4 dogs will develop cancer at some point, rising to about 1 in 2 for dogs 10 years and older. Accessed 2026-08-28.
- [5]CVM GFI #256: Compounding Animal Drugs from Bulk Drug Substances (FDA)regulatoryFDA's guidance describing the narrow conditions under which it will not act against animal drugs compounded from bulk substances - for non-food animals, by or on the order of a licensed veterinarian, when no approved option works. A research peptide bought online and injected without a vet is outside this. Accessed 2026-08-28.
- [6]Q&A: GFI #256 Compounding Animal Drugs from Bulk Drug Substances (FDA)regulatoryFDA's plain-language Q&A confirming that drugs compounded from bulk substances are not FDA-approved and do not meet approval, manufacturing or labeling requirements. Accessed 2026-08-28.
Pepteca is for education and information only. It does not provide medical advice, diagnosis, or treatment, and its calculators perform unit math only. Always verify with a licensed provider before starting, changing, or stopping any protocol. Many peptides are not approved for human use and may be regulated differently where you live.